We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.
MBII

Delisted

MBII was delisted on the 12th of July, 2022.

Back to rankings

53 hedge funds and large institutions have $69.1M invested in Marrone Bio Innovations, Inc. in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 1

23% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 13

20% more funds holding

Funds holding: 44 → 53 (+9)

4% more capital invested

Capital invested by funds: $66.5M → $69.1M (+$2.66M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
53
Holders Change
+9
Holders Change %
+20.45%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
10
Increased
16
Reduced
13
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$129K
2
FC
Fairpointe Capital
Illinois
+$89.7K
3
SG Americas Securities
SG Americas Securities
New York
+$74.2K
4
ECM
ExodusPoint Capital Management
New York
+$49.3K
5
SIM
Spark Investment Management
New York
+$46.7K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$252K
2
Morgan Stanley
Morgan Stanley
New York
-$150K
3
State Street
State Street
Massachusetts
-$148K
4
PP
Paloma Partners
Connecticut
-$59.5K
5
OAM
Oxford Asset Management
United Kingdom
-$51.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
WRF
1
Waddell & Reed Financial
Kansas
$37.8M – – –
AAP
2
Ardsley Advisory Partners
Connecticut
$13.7M +$2.29K +1,500 +0%
Vanguard Group
3
Vanguard Group
Pennsylvania
$4.08M +$129K +84,298 +3%
BlackRock
4
BlackRock
New York
$4.03M -$252K -165,227 -6%
Primecap Management
5
Primecap Management
California
$4.01M -$9.15K -6,000 -0.2%
State Street
6
State Street
Massachusetts
$1.25M -$148K -97,022 -11%
Northern Trust
7
Northern Trust
Illinois
$824K +$24.7K +16,161 +3%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$717K +$38.8K +25,430 +6%
IAM
9
ICM Asset Management
Washington
$396K – – –
FC
10
Fairpointe Capital
Illinois
$292K +$89.7K +58,760 +44%
Charles Schwab
11
Charles Schwab
California
$199K +$42.3K +27,730 +27%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$177K -$365 -239 -0.2%
SIM
13
Spark Investment Management
New York
$145K +$46.7K +30,600 +48%
California State Teachers Retirement System (CalSTRS)
14
California State Teachers Retirement System (CalSTRS)
California
$128K – – –
Wells Fargo
15
Wells Fargo
California
$121K +$4.24K +2,778 +4%
TA
16
Teachers Advisors
New York
$115K – – –
Deutsche Bank
17
Deutsche Bank
Germany
$103K -$4.28K -2,802 -4%
RhumbLine Advisers
18
RhumbLine Advisers
Massachusetts
$103K -$1.04K -685 -1%
TCIM
19
TIAA CREF Investment Management
New York
$81K +$58 +38 +0.1%
SG Americas Securities
20
SG Americas Securities
New York
$74K +$74.2K +48,643 New
Citadel Advisors
21
Citadel Advisors
Florida
$57K +$40.3K +26,429 +245%
AIG
22
American International Group
New York
$53K -$1.72K -1,127 -3%
VOYA Investment Management
23
VOYA Investment Management
Georgia
$50K – – –
State Board of Administration of Florida Retirement System
24
State Board of Administration of Florida Retirement System
Florida
$49K – – –
ECM
25
ExodusPoint Capital Management
New York
$49K +$49.3K +32,300 New
1
2 3

MBII Hedge Fund Activity: Q1 2019 in Review

53 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q1 2019, worth a combined $69.1M — up 4% from $66.5M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new MBII positions and 1 closed out — a net gain of 9 holders — while 16 added to existing stakes and 13 trimmed.

The largest buyer was Vanguard Group, adding an estimated $129K. The largest seller was BlackRock, cutting an estimated $252K.

  • 53 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q1 2019, up from 44 in Q4 2018.
  • Funds reported $69.1M of Marrone Bio Innovations, Inc. stock for Q1 2019, up 4% quarter-over-quarter.
  • 10 funds opened new Marrone Bio Innovations, Inc. positions in Q1 2019 and 1 closed out, a net change of +9 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q1 2019 was Vanguard Group, an estimated $129K added.
  • The largest Marrone Bio Innovations, Inc. seller in Q1 2019 was BlackRock, an estimated $252K sold.

Based on aggregated 13F filings for Q1 2019.